Baylor College of Medicine News

Baylor College of Medicine receives additional $9.7 million in state cancer grants

Baylor College of Medicine received $9.7 million in the newest wave of grants announced by the Cancer Prevention and Research Institute of Texas.

The new awards bring Baylor’s total CPRIT funding to more than $121 million since the agency started issuing cancer grants in 2010. 

“CPRIT is a unique and important funding resource for Texas oncology researchers, clinicians and advocates,” said Dr. Kent Osborne, director of Baylor’s NCI-designated Dan L. Duncan Cancer Center. “At Baylor, this new funding will help us continue critically important cancer prevention programs at Harris Health’s Ben Taub Hospital and Smith Clinic and initiate many new individual and high-risk, high-reward research projects that are likely to make a significant impact in the fight against cancer.”

The awards included:

Competitive Continuation/Expansion

  • Empowering the Medically Underserved Through a Community Network for Cancer Prevention – $1,499,234

Individual Investigator Research Awards

  • Novel Small Molecule Probes Targeting IDH Mutated Glioma – $695,527
  • Mechanisms of CTC Biomarkers in Breast Cancer Brain Metastasis – $899,968
  • Investigating and Preclinical Targeting Molecular Drivers of Muscle-Invasive Bladder Cancer – $827,451
  • Role of DNA METHYLTRANSFERASE 3A in Hematologic Malignancies – $900,000
  • Targeting Self-Renewal in Leukemic Stem Cells Through the Inactivation of KLF4 – $813,789
  • Role of DNA2 Nuclease in Cellular Tolerance of Replication Stress and Telomere Maintenance – Implications for Cancer Biology and Anticancer Therapy – $746,531
  • Translational Discovery of Resistance Genes and Cancer Gene Functions – $900,000
  • Tenascin-C and Metastatic Prostate Cancer Progression – $827,806
  • The Intersection Between Childhood Cancer and Congenital Anomalies: Identifying Novel Cancer Predisposition Syndromes – $874,964
  • Toll-Like Receptors, Gut Microbiota, and Risk of Colorectal Adenoma – $899,131

High-Impact/High-Risk Research Awards

  • Integrated Human Herpesvirus 6 as a Novel Heritable Risk Factor for Glioma – $199,298
  • Viral MicroRNAs in Ovarian Cancer Growth and Metastasis – $199,995
  • Context-Specific in Vivo Screening for KRAS-Associated Gene Aberration Drivers Using Genetically Engineered Mouse Models of Lung Cancer – $199,715